Tag Archives: Reported Adverse Events (RAEs)

Antipsychotics for Delirium in General Hospitals (International Journal of Geriatric Psychiatry)

Posted on September 5, 2013 by Dementia and Elderly Care News

Summary This article discusses a prospective observational study, conducted over 1 year at 33 general hospitals in Japan, into the risks and benefits of antipsychotics for older patients with delirium in general hospital settings. Of 2834 patients who developed delirium, 2453 … Continue reading →

Posted in Acute Hospitals, Antipsychotics, Delirium, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Pharmacological Treatments, Quick Insights | Tagged Adverse Drug Events, Adverse Drug Reactions, Adverse Events, Antipsychotic Medication for Delirium, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics for Delirium, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Atypical Antipsychotics, Care in General Hospitals, Chiba University, Clinical Global Impressions-Improvement Scale, Delirium Etiology Rating Checklist, Department of Psychiatry: Juntendo University Nerima Hospital, Drug Side-Effects, Extrapyramidal Symptoms, Fukushima Medical University, General Hospital Care, General Hospitals, Geriatric Psychiatry, Graduate School of Medicine: Chiba University, Haloperidol, Hiroshima University Hospital, International Journal of Geriatric Psychiatry, International Medical Center of Japan Kounodai Hospital, Japan, Japanese Red Cross Narita Hospital, Juntendo University Nerima Hospital: Tokyo, Juntendo University Urayasu Hospital, Kamiiida Daiichi General Hospital, Kikukawa General Hospital, Koyukai Memorial Hospital, Kurume University School of Medicine, Kyushu University Hospital, Nagano Red Cross Hospital, Nara Hospital Kinki University Faculty of Medicine, National Hospital Organization Osaka National Hospital, Nippon Medical School Musashikosugi Hospital, Osaka Red Cross Hospital, Parenteral Haloperidol, Perospirone, Quetiapine, Reported Adverse Events (RAEs), Risperidone, Serious Adverse Events, Shimane Prefectural Central Hospital, St. Luke's International Hospital, St. Marianna University School of Medicine, Toho University Sakura Medical Center, Tokyo Metropolitan Hiroo Hospital, Tokyo Metropolitan Tama Medical Center | Leave a comment

Johnson & Johnson Fined $1.1bn Over Risperdal: Subversion of Science? (BBC Health News / Drug Dangers)

Posted on April 13, 2012 by Dementia and Elderly Care News

Summary The drugs giant Johnson & Johnson (J&J) has been ordered by a US judge to pay $1.1bn (£690m) for downplaying the risks involved in taking its anti-psychotic drug Risperdal (Risperidone). This is only the latest of fines the company … Continue reading →

Posted in Antipsychotics, BBC News, In the News, International, Pharmacological Treatments, Quick Insights, Universal Interest | Tagged Adverse Drug Events, Adverse Drug Reactions, Adverse Events, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics in Elderly People with Dementia, Atypical Antipsychotics, BBC Health News, Complications, Drug Dangers (US Website), Drug Side-Effects, Local Involvement Networks (LINks), Prescribing Anti-Psychotic Drugs to People with Dementia, Reported Adverse Events (RAEs) | Leave a comment

The Impact of Dementia on Adverse Events in Older People Admitted to the Acute General Hospital

Posted on April 20, 2011 by Dementia and Elderly Care News

[A brief reference to this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 1 Issue 10, May 2011]. Abstract This study investigates the risk factors for reported adverse events (RAEs) in the acute hospital, in particular cognitive impairment … Continue reading →

Posted in Acute Hospitals, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Quick Insights, UK, Universal Interest | Tagged Acute Care, Acute Hospital Care, Care in General Hospitals, Dementia Care in Acute District General Hospitals, Dementia in General Hospital Inpatients, General Hospital Care, RAEs: Reported Adverse Events, Reported Adverse Events (RAEs) | Leave a comment

Tag Archives: Reported Adverse Events (RAEs)

Johnson & Johnson Fined $1.1bn Over Risperdal: Subversion of Science? (BBC Health News / Drug Dangers)

The Impact of Dementia on Adverse Events in Older People Admitted to the Acute General Hospital

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites